Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 11;18(5):e0284130.
doi: 10.1371/journal.pone.0284130. eCollection 2023.

Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand

Kannikar Intawong  1 , Suwat Chariyalertsak  1 , Kittipan Chalom  2 , Thanachol Wonghirundecha  2 , Woravut Kowatcharakul  3 , Aksara Thongprachum  1 , Narain Chotirosniramit  4 , Kajohnsak Noppakun  4 , Krit Khwanngern  4 , Worachet Teacharak  5 , Prapon Piamanant  5 , Pannawich Chantaklang  5 , Pimpinan Khammawan  5
Affiliations

Waning vaccine response to severe COVID-19 outcomes during omicron predominance in Thailand

Kannikar Intawong et al. PLoS One. .

Abstract

Background: The COVID-19 pandemic has evolved quickly, with different variants of concern resulting in the need to offer continued protection through booster vaccinations. The duration of enhanced protection with booster doses against severe COVID-19 is still unclear. Understanding this is critical to recommendations on the frequency of future booster doses.

Methods: Utilising a Hospital Information System for COVID-19 established in Chiang Mai, Thailand, we conducted a cohort study by linking patient-level data of laboratory-confirmed COVID-19 cases to the national immunization records, during the omicron predominant period (1 February- 31 July 2022).

Results: Out of 261,103 adults with COVID-19 included in the study, there were 333 (0.13%) severe COVID-19 cases and 190 (0.07%) deaths. Protection against severe COVID-19 was highest with boosters received >14-60 days prior to positive test (93%) and persisted at >60-120 days (91%) but started to wane at >120-180 days (77%) and further at >180 days (68%). The rate of waning differed with age. Those ≥70 years showed faster waning of booster vaccine responses as compared to those aged 18-49 years, who retained good responses up to 180 days. Equivalent risk reduction against severe COVID-19 was seen with all the vaccine types used as boosters in Thailand.

Conclusions: Booster doses provided high levels of protection against severe COVID-19 with omicron, up to 4 months. Repeat boosters will be required to continue protection beyond 4 months, particularly in the elderly. mRNA and viral vector vaccines can be used flexibly to improve booster coverage.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Adjusted risk reduction (95% CI) of severe COVID-19 among adults during omicron predominance, by vaccination regimens and time since last vaccine dose.
Fig 2
Fig 2. Adjusted risk reduction (95% CI) of severe COVID-19 among adults during omicron predominance, by vaccination regimens and time since last vaccine dose, stratified by age group.
See this image and copyright information in PMC

References

    1. Our World in Data. Coronavirus Pandemic (COVID-19). Available online at https://ourworldindata.org/coronavirus. [Last accessed 30 January 2023].
    1. GISAID, nCoV-19 Variants Dashboard. Available online at https://gisaid.org/hcov-19-variants-dashboard/ [Last accessed 1 December 2022].
    1. Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al.. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185(14):2422–2433.e13. doi: 10.1016/j.cell.2022.06.005 - DOI - PMC - PubMed
    1. Doroshenko A. The Combined Effect of Vaccination and Nonpharmaceutical Public Health Interventions-Ending the COVID-19 Pandemic. JAMA Netw Open. 2021;4(6):e2111675. doi: 10.1001/jamanetworkopen.2021.11675 - DOI - PubMed
    1. Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis 2021;S1473–3099(21)00143-2. doi: 10.1016/S1473-3099(21)00143-2 - DOI - PMC - PubMed

Publication types